Sinofn Health
Sinofn Health
Vitamin A is not just a nutrient; it is a fundamental pillar of human health, metabolic regulation, and immune optimization. In the global nutraceutical industry, sourcing Vitamin A requires more than just commodity purchasing—it demands an "OEM SINOFN" approach: where manufacturer expertise meets rigorous scientific validation.
Modern global brands face a dilemma: how to balance high-volume demand with bioavailability and regulatory compliance. Vitamin A (Retinol/Retinyl Palmitate) formulations are sensitive. Our procurement strategy focuses on three pillars: Stability, Bioavailability, and Regulatory Traceability. SINOFN leverages advanced encapsulation technology to ensure the payload survives the manufacturing and digestive journey.
The industry is transitioning from generic supplementation to precision nutrition. We observe a market shift toward specialized diets (FSMP) and age-specific formulations. SINOFN acts as a bridge, utilizing our Tianjin R&D center, backed by the Chinese Academy of Sciences, to innovate delivery systems that outperform traditional synthetic counterparts.
Moving beyond standard powder blends, we are developing micro-encapsulation techniques that protect Vitamin A from oxidation, ensuring 99% shelf-life stability.
Integrating our PKU food research methodologies to create Vitamin A derivatives that support specific metabolic pathways, targeting cognitive and cellular performance.
Our infrastructure is designed for EU, FDA, and Asian compliance. We manage the complexity of global trade so our partners can focus on distribution.
Founded in 2012 by Mrs. GuoHong Liu, SINOFN is built on the intersection of medical necessity and industrial capability. Our R&D team, led by Dr. Tan Shengjie and Dr. Zhang Ying, represents the highest tier of scientific rigor. We do not just manufacture; we innovate.
We recognize that global markets require local adherence. From Halal certifications to GMP and FSSC 22000 standards, our factory tour (physical and virtual) showcases a commitment to transparency. We bridge the gap between Chinese manufacturing efficiency and Western quality expectations through rigid batch tracking and blockchain-enabled supply chain monitoring.
We operate a state-of-the-art facility in China with global export capabilities, serving high-growth markets in Europe, North America, and Asia.
Yes. Our R&D center focuses on pilot-scale prototyping for tablets, capsules, and liquids, allowing brands to test market viability quickly.
Beyond competitive pricing, we offer scientific legitimacy. Our partnership with the Chinese Academy of Sciences ensures your product is formulated by the best.
